Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Feb;70(2):843–851. doi: 10.1128/jvi.70.2.843-851.1996

Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.

U Utz 1, D Banks 1, S Jacobson 1, W E Biddison 1
PMCID: PMC189887  PMID: 8551623

Abstract

Human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive neurological disease characterized by marked degeneration of the spinal cord and the presence of antibodies against HTLV-1. Patients with HAM/TSP, but not asymptomatic carriers, show very high precursor frequencies of HTLV-1-specific CD8+ T cells in peripheral blood and cerebrospinal fluid, suggestive of a role of these T cells in the pathogenesis of the disease. In HLA-A2+ HAM/TSP patients, HTLV-1-specific T cells were demonstrated to be directed predominantly against one HTLV-1 epitope, namely, Tax11-19. In the present study, we analyzed HLA-A2-restricted HTLV-1 Tax11-19-specific cytotoxic T cells from three patients with HAM/TSP. An analysis of the T-cell receptor (TCR) repertoire of these cells revealed an absence of restricted variable (V) region usage. Different combinations of TCR V alpha and V beta genes were utilized between, but also within, the individual patients for the recognition of Tax11-19. Sequence analysis of the TCR showed evidence for an oligoclonal expansion of few founder T cells in each patient. Apparent structural motifs were identified for the CDR3 regions of the TCR beta chains. One T-cell clone could be detected within the same patient over a period of 3 years. We suggest that these in vivo clonally expanded T cells might play a role in the pathogenesis of HAM/TSP and provide information on HTLV-1-specific TCR which may elucidate the nature of the T cells that infiltrate the central nervous system in HAM/TSP patients.

Full Text

The Full Text of this article is available as a PDF (459.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Argaet V. P., Schmidt C. W., Burrows S. R., Silins S. L., Kurilla M. G., Doolan D. L., Suhrbier A., Moss D. J., Kieff E., Sculley T. B. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med. 1994 Dec 1;180(6):2335–2340. doi: 10.1084/jem.180.6.2335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ben-Nun A., Liblau R. S., Cohen L., Lehmann D., Tournier-Lasserve E., Rosenzweig A., Zhang J. W., Raus J. C., Bach M. A. Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2466–2470. doi: 10.1073/pnas.88.6.2466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bentley G. A., Boulot G., Karjalainen K., Mariuzza R. A. Crystal structure of the beta chain of a T cell antigen receptor. Science. 1995 Mar 31;267(5206):1984–1987. doi: 10.1126/science.7701320. [DOI] [PubMed] [Google Scholar]
  4. Boitel B., Blank U., Mège D., Corradin G., Sidney J., Sette A., Acuto O. Strong similarities in antigen fine specificity among DRB1* 1302-restricted tetanus toxin tt830-843-specific TCRs in spite of highly heterogeneous CDR3. J Immunol. 1995 Apr 1;154(7):3245–3255. [PubMed] [Google Scholar]
  5. Chien Y. H., Davis M. M. How alpha beta T-cell receptors 'see' peptide/MHC complexes. Immunol Today. 1993 Dec;14(12):597–602. doi: 10.1016/0167-5699(93)90199-u. [DOI] [PubMed] [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  7. Claverie J. M., Prochnicka-Chalufour A., Bougueleret L. Implications of a Fab-like structure for the T-cell receptor. Immunol Today. 1989 Jan;10(1):10–14. doi: 10.1016/0167-5699(89)90058-3. [DOI] [PubMed] [Google Scholar]
  8. Davis M. M., Bjorkman P. J. T-cell antigen receptor genes and T-cell recognition. Nature. 1988 Aug 4;334(6181):395–402. doi: 10.1038/334395a0. [DOI] [PubMed] [Google Scholar]
  9. DiBrino M., Parker K. C., Shiloach J., Knierman M., Lukszo J., Turner R. V., Biddison W. E., Coligan J. E. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1508–1512. doi: 10.1073/pnas.90.4.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Elovaara I., Koenig S., Brewah A. Y., Woods R. M., Lehky T., Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med. 1993 Jun 1;177(6):1567–1573. doi: 10.1084/jem.177.6.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Giegerich G., Pette M., Meinl E., Epplen J. T., Wekerle H., Hinkkanen A. Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes. Eur J Immunol. 1992 Mar;22(3):753–758. doi: 10.1002/eji.1830220319. [DOI] [PubMed] [Google Scholar]
  12. Hara H., Morita M., Iwaki T., Hatae T., Itoyama Y., Kitamoto T., Akizuki S., Goto I., Watanabe T. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med. 1994 Sep 1;180(3):831–839. doi: 10.1084/jem.180.3.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heber-Katz E., Acha-Orbea H. The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol Today. 1989 May;10(5):164–169. doi: 10.1016/0167-5699(89)90174-6. [DOI] [PubMed] [Google Scholar]
  14. Hogan K. T., Shimojo N., Walk S. F., Engelhard V. H., Maloy W. L., Coligan J. E., Biddison W. E. Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide. J Exp Med. 1988 Aug 1;168(2):725–736. doi: 10.1084/jem.168.2.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Höllsberg P., Hafler D. A. What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis? Ann Neurol. 1995 Feb;37(2):143–145. doi: 10.1002/ana.410370203. [DOI] [PubMed] [Google Scholar]
  16. Imarai M., Goyarts E. C., van Bleek G. M., Nathenson S. G. Diversity of T cell receptors specific for the VSV antigenic peptide (N52-59) bound by the H-2Kb class I molecule. Cell Immunol. 1995 Jan;160(1):33–42. doi: 10.1016/0008-8749(95)80006-5. [DOI] [PubMed] [Google Scholar]
  17. Jacobson S., Gupta A., Mattson D., Mingioli E., McFarlin D. E. Immunological studies in tropical spastic paraparesis. Ann Neurol. 1990 Feb;27(2):149–156. doi: 10.1002/ana.410270209. [DOI] [PubMed] [Google Scholar]
  18. Jacobson S., McFarlin D. E., Robinson S., Voskuhl R., Martin R., Brewah A., Newell A. J., Koenig S. HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann Neurol. 1992 Nov;32(5):651–657. doi: 10.1002/ana.410320508. [DOI] [PubMed] [Google Scholar]
  19. Jacobson S., Shida H., McFarlin D. E., Fauci A. S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990 Nov 15;348(6298):245–248. doi: 10.1038/348245a0. [DOI] [PubMed] [Google Scholar]
  20. Jorgensen J. L., Esser U., Fazekas de St Groth B., Reay P. A., Davis M. M. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature. 1992 Jan 16;355(6357):224–230. doi: 10.1038/355224a0. [DOI] [PubMed] [Google Scholar]
  21. Koenig S., Woods R. M., Brewah Y. A., Newell A. J., Jones G. M., Boone E., Adelsberger J. W., Baseler M. W., Robinson S. M., Jacobson S. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol. 1993 Oct 1;151(7):3874–3883. [PubMed] [Google Scholar]
  22. Koike T., Kagami M., Takabayashi K., Maruyama N., Tomioka H., Yoshida S. Antibodies to human T cell leukemia virus are absent in patients with systemic lupus erythematosus. Arthritis Rheum. 1985 May;28(5):481–484. doi: 10.1002/art.1780280502. [DOI] [PubMed] [Google Scholar]
  23. Kubota R., Umehara F., Izumo S., Ijichi S., Matsumuro K., Yashiki S., Fujiyoshi T., Sonoda S., Osame M. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol. 1994 Aug;53(1):23–29. doi: 10.1016/0165-5728(94)90060-4. [DOI] [PubMed] [Google Scholar]
  24. Kuroda Y., Matsui M., Kikuchi M., Kurohara K., Endo C., Yukitake M., Matsuda Y., Tokunaga O., Komine-Sakaki A., Kawaguchi R. In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy. Neurology. 1994 Dec;44(12):2295–2299. doi: 10.1212/wnl.44.12.2295. [DOI] [PubMed] [Google Scholar]
  25. Lehner P. J., Wang E. C., Moss P. A., Williams S., Platt K., Friedman S. M., Bell J. I., Borysiewicz L. K. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med. 1995 Jan 1;181(1):79–91. doi: 10.1084/jem.181.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Madden D. R., Garboczi D. N., Wiley D. C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 1993 Nov 19;75(4):693–708. doi: 10.1016/0092-8674(93)90490-h. [DOI] [PubMed] [Google Scholar]
  27. Man S., Ridge J. P., Engelhard V. H. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice. J Immunol. 1994 Nov 15;153(10):4458–4467. [PubMed] [Google Scholar]
  28. Martin R., Utz U., Coligan J. E., Richert J. R., Flerlage M., Robinson E., Stone R., Biddison W. E., McFarlin D. E., McFarland H. F. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol. 1992 Mar 1;148(5):1359–1366. [PubMed] [Google Scholar]
  29. Masuko K., Kato T., Ikeda Y., Okubo M., Mizushima Y., Nishioka K., Yamamoto K. Dynamic changes of accumulated T cell clonotypes during antigenic stimulation in vivo and in vitro. Int Immunol. 1994 Dec;6(12):1959–1966. doi: 10.1093/intimm/6.12.1959. [DOI] [PubMed] [Google Scholar]
  30. Moore G. R., Traugott U., Scheinberg L. C., Raine C. S. Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol. 1989 Oct;26(4):523–530. doi: 10.1002/ana.410260405. [DOI] [PubMed] [Google Scholar]
  31. Moss P. A., Moots R. J., Rosenberg W. M., Rowland-Jones S. J., Bodmer H. C., McMichael A. J., Bell J. I. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8987–8990. doi: 10.1073/pnas.88.20.8987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Oksenberg J. R., Panzara M. A., Begovich A. B., Mitchell D., Erlich H. A., Murray R. S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C. C. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 1993 Mar 4;362(6415):68–70. doi: 10.1038/362068a0. [DOI] [PubMed] [Google Scholar]
  33. Oksenberg J. R., Stuart S., Begovich A. B., Bell R. B., Erlich H. A., Steinman L., Bernard C. C. Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature. 1990 May 24;345(6273):344–346. doi: 10.1038/345344a0. [DOI] [PubMed] [Google Scholar]
  34. Rock E. P., Sibbald P. R., Davis M. M., Chien Y. H. CDR3 length in antigen-specific immune receptors. J Exp Med. 1994 Jan 1;179(1):323–328. doi: 10.1084/jem.179.1.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Román G. C., Osame M. Identity of HTLV-I-associated tropical spastic paraparesis and HTLV-I-associated myelopathy. Lancet. 1988 Mar 19;1(8586):651–651. doi: 10.1016/s0140-6736(88)91452-3. [DOI] [PubMed] [Google Scholar]
  36. Rotteveel F. T., Kokkelink I., van Walbeek H. K., Polman C. H., van Dongen J. J., Lucas C. L. Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol. 1987 Jul-Aug;15(3):243–249. doi: 10.1016/0165-5728(87)90119-6. [DOI] [PubMed] [Google Scholar]
  37. Rowbotham M. C., Davies P. S., Fields H. L. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 1995 Feb;37(2):246–253. doi: 10.1002/ana.410370216. [DOI] [PubMed] [Google Scholar]
  38. Salvetti M., Ristori G., D'Amato M., Buttinelli C., Falcone M., Fieschi C., Wekerle H., Pozzilli C. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur J Immunol. 1993 Jun;23(6):1232–1239. doi: 10.1002/eji.1830230606. [DOI] [PubMed] [Google Scholar]
  39. Shimojo N., Anderson R. W., Mattson D. H., Turner R. V., Coligan J. E., Biddison W. E. The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove. Int Immunol. 1990;2(3):193–200. doi: 10.1093/intimm/2.3.193. [DOI] [PubMed] [Google Scholar]
  40. Storkus W. J., Howell D. N., Salter R. D., Dawson J. R., Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol. 1987 Mar 15;138(6):1657–1659. [PubMed] [Google Scholar]
  41. Umehara F., Izumo S., Nakagawa M., Ronquillo A. T., Takahashi K., Matsumuro K., Sato E., Osame M. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1993 Jul;52(4):424–430. doi: 10.1097/00005072-199307000-00010. [DOI] [PubMed] [Google Scholar]
  42. Utz U., Koenig S., Coligan J. E., Biddison W. E. Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J Immunol. 1992 Jul 1;149(1):214–221. [PubMed] [Google Scholar]
  43. Vernant J. C., Buisson G., Magdeleine J., De Thore J., Jouannelle A., Neisson-Vernant C., Monplaisir N. T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome. Lancet. 1988 Jan 23;1(8578):177–177. doi: 10.1016/s0140-6736(88)92744-4. [DOI] [PubMed] [Google Scholar]
  44. Waksman B. H. Multiple sclerosis. Relationship to a retrovirus? Nature. 1989 Feb 16;337(6208):599–599. doi: 10.1038/337599a0. [DOI] [PubMed] [Google Scholar]
  45. Wilson D. B., Steinman L., Gold D. P. The V-region disease hypothesis: new evidence suggests it is probably wrong. Immunol Today. 1993 Aug;14(8):376–382. doi: 10.1016/0167-5699(93)90136-9. [DOI] [PubMed] [Google Scholar]
  46. Wu E., Dickson D. W., Jacobson S., Raine C. S. Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations. Acta Neuropathol. 1993;86(3):224–235. doi: 10.1007/BF00304136. [DOI] [PubMed] [Google Scholar]
  47. Wucherpfennig K. W., Ota K., Endo N., Seidman J. G., Rosenzweig A., Weiner H. L., Hafler D. A. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science. 1990 May 25;248(4958):1016–1019. doi: 10.1126/science.1693015. [DOI] [PubMed] [Google Scholar]
  48. Wucherpfennig K. W., Zhang J., Witek C., Matsui M., Modabber Y., Ota K., Hafler D. A. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol. 1994 Jun 1;152(11):5581–5592. [PubMed] [Google Scholar]
  49. Zamvil S. S., Mitchell D. J., Lee N. E., Moore A. C., Waldor M. K., Sakai K., Rothbard J. B., McDevitt H. O., Steinman L., Acha-Orbea H. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J Exp Med. 1988 May 1;167(5):1586–1596. doi: 10.1084/jem.167.5.1586. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES